HeraMED Ltd. (AU:HMD) has released an update.
HeraMED Limited has announced the cessation of 7.5 million options due to unmet conditions. The options, which were set to expire on December 31, 2025, at an exercise price of $0.0975, ceased on May 1, 2024. This development could influence the company’s market position and investor decisions.
For further insights into AU:HMD stock, check out TipRanks’ Stock Analysis page.
